These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 33935088)

  • 1. Association Between the APOEɛ2/ɛ4 Genotype and Alzheimer's Disease and Mild Cognitive Impairment Among African Americans.
    Ren D; Lopez OL; Lingler JH; Conley Y
    J Alzheimers Dis; 2021; 81(3):943-948. PubMed ID: 33935088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of the APOE ε2ε4 Genotype on the Development of Alzheimer's Disease (AD) and Mild Cognitive Impairment (MCI) in Non-Latino Whites.
    Ren D; Lopez OL; Lingler JH; Conley Y
    J Am Geriatr Soc; 2020 May; 68(5):1044-1049. PubMed ID: 32017008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Segmented Linear Mixed Model Analysis Reveals Association of the APOEɛ4 Allele with Faster Rate of Alzheimer's Disease Dementia Progression.
    Chen XR; Shao Y; Sadowski MJ;
    J Alzheimers Dis; 2021; 82(3):921-937. PubMed ID: 34120907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E ɛ4 (APOE ɛ4) Allele is Associated with Long Sleep Duration Among Elderly with Cognitive Impairment.
    Basta M; Zaganas I; Simos P; Koutentaki E; Dimovasili C; Mathioudakis L; Bourbouli M; Panagiotakis S; Kapetanaki S; Vgontzas A
    J Alzheimers Dis; 2021; 79(2):763-771. PubMed ID: 33361595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between Apolipoprotein E and Butyrylcholinesterase Genes on Risk of Alzheimer's Disease in a Prospective Cohort Study.
    Chuang YF; Varma V; An Y; Tanaka T; Davatzikos C; Resnick SM; Thambisetty M
    J Alzheimers Dis; 2020; 75(2):417-427. PubMed ID: 32250307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topographical APOE ɛ4 Genotype Influence on Cerebral Metabolism in the Continuum of Alzheimer's Disease: Amyloid Burden Adjusted Analysis.
    Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
    J Alzheimers Dis; 2016 Sep; 54(2):559-68. PubMed ID: 27567846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of mild cognitive impairment and APOE genotype on resting cerebral blood flow and its association with cognition.
    Wierenga CE; Dev SI; Shin DD; Clark LR; Bangen KJ; Jak AJ; Rissman RA; Liu TT; Salmon DP; Bondi MW
    J Cereb Blood Flow Metab; 2012 Aug; 32(8):1589-99. PubMed ID: 22549621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
    J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Alzheimer's Disease and Mild Cognitive Impairment in Older Adults in Panama.
    Villarreal AE; Grajales S; O'Bryant SE; Edwards M; López L; Montalván A; Britton GB;
    J Alzheimers Dis; 2016 Oct; 54(3):897-901. PubMed ID: 27567849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-Year Change in Body Mass Index Predicts Conversion to Mild Cognitive Impairment or Dementia Only in APOE ɛ4 Allele Carriers.
    Kadey KR; Woodard JL; Moll AC; Nielson KA; Smith JC; Durgerian S; Rao SM
    J Alzheimers Dis; 2021; 81(1):189-199. PubMed ID: 33749649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease.
    Khan W; Giampietro V; Banaschewski T; Barker GJ; Bokde AL; Büchel C; Conrod P; Flor H; Frouin V; Garavan H; Gowland P; Heinz A; Ittermann B; Lemaître H; Nees F; Paus T; Pausova Z; Rietschel M; Smolka MN; Ströhle A; Gallinat J; Vellas B; Soininen H; Kloszewska I; Tsolaki M; Mecocci P; Spenger C; Villemagne VL; Masters CL; Muehlboeck JS; Bäckman L; Fratiglioni L; Kalpouzos G; Wahlund LO; Schumann G; Lovestone S; Williams SC; Westman E; Simmons A; ; ;
    J Alzheimers Dis; 2017; 56(3):1159-1174. PubMed ID: 28157104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total Cholesterol and APOE-Related Risk for Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative.
    Dunk MM; Driscoll I;
    J Alzheimers Dis; 2022; 85(4):1519-1528. PubMed ID: 34958023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment.
    Lacour A; Espinosa A; Louwersheimer E; Heilmann S; Hernández I; Wolfsgruber S; Fernández V; Wagner H; Rosende-Roca M; Mauleón A; Moreno-Grau S; Vargas L; Pijnenburg YA; Koene T; Rodríguez-Gómez O; Ortega G; Ruiz S; Holstege H; Sotolongo-Grau O; Kornhuber J; Peters O; Frölich L; Hüll M; Rüther E; Wiltfang J; Scherer M; Riedel-Heller S; Alegret M; Nöthen MM; Scheltens P; Wagner M; Tárraga L; Jessen F; Boada M; Maier W; van der Flier WM; Becker T; Ramirez A; Ruiz A
    Mol Psychiatry; 2017 Jan; 22(1):153-160. PubMed ID: 26976043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.
    De Beaumont L; Pelleieux S; Lamarre-Théroux L; Dea D; Poirier J;
    J Alzheimers Dis; 2016 Oct; 54(3):913-922. PubMed ID: 27567841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of
    Qian J; Betensky RA; Hyman BT; Serrano-Pozo A
    Neurology; 2021 May; 96(19):e2414-e2428. PubMed ID: 33771840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
    Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV
    Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral atrophy, apolipoprotein E varepsilon4, and rate of decline in everyday function among patients with amnestic mild cognitive impairment.
    Okonkwo OC; Alosco ML; Jerskey BA; Sweet LH; Ott BR; Tremont G;
    Alzheimers Dement; 2010 Sep; 6(5):404-11. PubMed ID: 20813341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E genotypes and plasma levels in mild cognitive impairment conversion to Alzheimer's disease: A follow-up study.
    Scarabino D; Broggio E; Gambina G; Maida C; Gaudio MR; Corbo RM
    Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1131-1138. PubMed ID: 27604972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of genetic and health risk factors for mild cognitive impairment and Alzheimer's disease between Hispanic and non-Hispanic white participants.
    Xiao C; Pappas I; Aksman LM; O'Bryant SE; Toga AW;
    Alzheimers Dement; 2023 Nov; 19(11):5086-5094. PubMed ID: 37104247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic influence of apolipoprotein E4 genotype on hippocampal morphometry: An N = 725 surface-based Alzheimer's disease neuroimaging initiative study.
    Shi J; Leporé N; Gutman BA; Thompson PM; Baxter LC; Caselli RJ; Wang Y;
    Hum Brain Mapp; 2014 Aug; 35(8):3903-18. PubMed ID: 24453132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.